Dataset: Transcriptional analysis of multiple brain regions in Parkinson's disease
Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy...
Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. This SuperSeries is composed of the following subset Series: GSE20168: Transcriptional analysis of prefrontal area 9 in Parkinson's disease GSE20291: Transcriptional analysis of putamen in Parkinson's disease GSE20292: Transcriptional analysis of whole substantia nigra in Parkinson's disease Refer to individual Series
- Species:
- human
- Samples:
- 85
- Source:
- E-GEOD-20295
- PubMed:
- 15965975
- Updated:
- Dec.12, 2014
- Registered:
- Jun.19, 2014
Factors:
(via ArrayExpress)
| Sample | DISEASE STATE | GENDER | AGE | BRAIN REGION |
|---|---|---|---|---|
| GSM50605 | control | male | 67 | Prefrontal cortex area 9 |
| GSM506045 | Parkinson's disease | male | 70 | Prefrontal cortex area 9 |
| GSM508608 | Parkinsons disease | male | 73 | Putamen from postmortem brain |
| GSM508734 | Control | male | 81 | Whole substantia nigra from postmortem brain |
| GSM506053 | control | female | 73 | Prefrontal cortex area 9 |
| GSM508695 | Parkinsons disease | male | 75 | Putamen from postmortem brain |
| GSM508696 | Control | male | 74 | Putamen from postmortem brain |
| GSM50606 | control | female | 72 | Prefrontal cortex area 9 |
| GSM508692 | Control | female | 73 | Putamen from postmortem brain |
| GSM508699 | Control | female | 72 | Putamen from postmortem brain |
| GSM5087 | Parkinsons disease | female | 80 | Whole substantia nigra from postmortem brain |
| GSM508629 | Parkinsons disease | male | 70 | Putamen from postmortem brain |
| GSM508608 | Parkinsons disease | male | 73 | Putamen from postmortem brain |
| GSM508683 | Control | female | 94 | Putamen from postmortem brain |
| GSM506040 | Parkinson's disease | female | 80 | Prefrontal cortex area 9 |
| GSM508728 | Parkinsons disease | male | 75 | Whole substantia nigra from postmortem brain |
| GSM508693 | Control | male | 60 | Putamen from postmortem brain |
| GSM508730 | Control | female | 72 | Whole substantia nigra from postmortem brain |
| GSM508699 | Control | female | 72 | Putamen from postmortem brain |
| GSM508703 | Control | male | 81 | Putamen from postmortem brain |
| GSM506068 | Parkinson's disease | male | 89 | Prefrontal cortex area 9 |
| GSM508730 | Control | female | 72 | Whole substantia nigra from postmortem brain |
| GSM508729 | Control | male | 74 | Whole substantia nigra from postmortem brain |
| GSM521253 | Control | male | 59 | Whole substantia nigra from postmortem brain |
| GSM506045 | Parkinson's disease | male | 70 | Prefrontal cortex area 9 |
| GSM508688 | Control | male | 54 | Putamen from postmortem brain |
| GSM508712 | Parkinsons disease | female | 84 | Whole substantia nigra from postmortem brain |
| GSM508705 | Control | male | 55 | Putamen from postmortem brain |
| GSM506043 | Parkinson's disease | female | 70 | Prefrontal cortex area 9 |
| GSM506065 | control | male | 81 | Prefrontal cortex area 9 |
| GSM508609 | Parkinsons disease | female | 80 | Putamen from postmortem brain |
| GSM506047 | control | female | 94 | Prefrontal cortex area 9 |
| GSM506042 | Parkinson's disease | female | 84 | Prefrontal cortex area 9 |
| GSM508715 | Parkinsons disease | male | 70 | Whole substantia nigra from postmortem brain |
| GSM50604 | Parkinson's disease | female | 78 | Prefrontal cortex area 9 |
| GSM506067 | control | male | 55 | Prefrontal cortex area 9 |
| GSM506063 | Parkinson's disease | male | 67 | Prefrontal cortex area 9 |
| GSM508732 | Parkinsons disease | male | 67 | Whole substantia nigra from postmortem brain |
| GSM508629 | Parkinsons disease | male | 70 | Putamen from postmortem brain |
| GSM50606 | control | female | 72 | Prefrontal cortex area 9 |
| GSM508704 | Parkinsons disease | male | 81 | Putamen from postmortem brain |
| GSM508723 | Control | female | 73 | Whole substantia nigra from postmortem brain |
| GSM508713 | Parkinsons disease | female | 70 | Whole substantia nigra from postmortem brain |
| GSM508720 | Control | male | 79 | Whole substantia nigra from postmortem brain |
| GSM508706 | Parkinsons disease | male | 89 | Putamen from postmortem brain |
| GSM508724 | Control | male | 82 | Whole substantia nigra from postmortem brain |
| GSM508700 | Parkinsons disease | female | 79 | Putamen from postmortem brain |
| GSM508610 | Parkinsons disease | female | 78 | Putamen from postmortem brain |
| GSM508702 | Control | male | 75 | Putamen from postmortem brain |
| GSM508733 | Control | male | 75 | Whole substantia nigra from postmortem brain |
| GSM506037 | control | male | 57 | Prefrontal cortex area 9 |
| GSM508722 | Control | male | 54 | Whole substantia nigra from postmortem brain |
| GSM506064 | control | male | 75 | Prefrontal cortex area 9 |
| GSM50866 | Parkinsons disease | male | 80 | Putamen from postmortem brain |
| GSM506050 | control | male | 79 | Prefrontal cortex area 9 |
| GSM506052 | control | male | 54 | Prefrontal cortex area 9 |
| GSM506039 | Parkinson's disease | male | 73 | Prefrontal cortex area 9 |
| GSM508715 | Parkinsons disease | male | 70 | Whole substantia nigra from postmortem brain |
| GSM508687 | Control | male | 67 | Putamen from postmortem brain |
| GSM508627 | Parkinsons disease | female | 70 | Putamen from postmortem brain |
| GSM506059 | Parkinson's disease | male | 75 | Prefrontal cortex area 9 |
| GSM50873 | Parkinsons disease | female | 79 | Whole substantia nigra from postmortem brain |
| GSM506062 | Parkinson's disease | female | 79 | Prefrontal cortex area 9 |
| GSM508735 | Control | male | 55 | Whole substantia nigra from postmortem brain |
| GSM506053 | control | female | 73 | Prefrontal cortex area 9 |
| GSM508690 | Control | male | 82 | Putamen from postmortem brain |
| GSM508692 | Control | female | 73 | Putamen from postmortem brain |
| GSM506044 | Parkinson's disease | female | 82 | Prefrontal cortex area 9 |
| GSM50872 | Control | male | 67 | Whole substantia nigra from postmortem brain |
| GSM506066 | Parkinson's disease | male | 81 | Prefrontal cortex area 9 |
| GSM5086 | Parkinsons disease | female | 84 | Putamen from postmortem brain |
| GSM508714 | Parkinsons disease | female | 82 | Whole substantia nigra from postmortem brain |
| GSM508710 | Parkinsons disease | male | 73 | Whole substantia nigra from postmortem brain |
| GSM508723 | Control | female | 73 | Whole substantia nigra from postmortem brain |
| GSM508594 | Control | male | 57 | Putamen from postmortem brain |
| GSM508717 | Control | female | 94 | Whole substantia nigra from postmortem brain |
| GSM508716 | Parkinsons disease | male | 80 | Whole substantia nigra from postmortem brain |
| GSM508628 | Parkinsons disease | female | 82 | Putamen from postmortem brain |
| GSM506057 | control | male | 60 | Prefrontal cortex area 9 |
| GSM506046 | Parkinson's disease | male | 80 | Prefrontal cortex area 9 |
| GSM508686 | Control | male | 79 | Putamen from postmortem brain |
| GSM50870 | Parkinsons disease | male | 67 | Putamen from postmortem brain |
| GSM506054 | control | male | 82 | Prefrontal cortex area 9 |
| GSM506060 | control | male | 74 | Prefrontal cortex area 9 |
| GSM508708 | Control | male | 57 | Whole substantia nigra from postmortem brain |